StockComparison Logo
vs

XPH vs CEFS

Comparison between STATE STREET(R) SPDR(R) S&P(R) PHARMACEUTICALS ETF (XPH, ETF) and SABA CLOSED-END FUNDS ETF (CEFS, ETF).

5-Year PerformanceCEFS has outperformed XPH, delivering a return of +14.1% compared to +7.2%

XPH vs CEFS - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Net Assets
Winner
XPH
$428M
CEFS
$427M
Expense Ratio
Winner
XPH
0.35%
CEFS
2.61%
Max Drawdown
XPH
52.72%
Winner
CEFS
41.61%
Sharpe Ratio
Winner
XPH
2.15
CEFS
1.47
5Y Beta
XPH
0.75
Winner
CEFS
0.54
P/E Ratio
XPH
-23.50
CEFS
N/A
Forward P/E
XPH
10.31
CEFS
N/A
5Y Dividends CAGR
Winner
XPH
5.58%
CEFS
2.98%
Debt to Equity
XPH
-615.82%
CEFS
N/A
P/S Ratio
XPH
2.71
CEFS
N/A
P/B Ratio
XPH
3.87
CEFS
N/A

XPH vs CEFS - Holdings Comparison

XPH and CEFS have 1 common holdings. Overlap is -6.51%

XPH's top 25 holdings weight is 50.17%. CEFS's top 25 holdings weight is 97.88%.

RankXPHCEFS
#1
CRINETICS PHARMACEUTICALS INC (CRNX) - 3.71%
n/a (BSTZ) - 13.17%
#2
n/a (DFTX) - 2.98%
CASH & CASH EQUIVALENTS (n/a) - 10.91%
#3
MBX BIOSCIENCES INC (MBX) - 2.97%
ASA GOLD AND PRECIOUS METALS (ASA) - 8.09%
#4
ENLIVEN THERAPEUTICS INC (ELVN) - 2.18%
n/a (NFJ) - 7.81%
#5
ALUMIS INC (ALMS) - 2.18%
BNP SHORT CASH ACCT (n/a) - 7.77%
#6
ATAIBECKLEY INC (ATAI) - 2.15%
BLACKROCK ESG CAPITAL ALLOCATION TRUST (ECAT) - 6.40%
#7
TREVI THERAPEUTICS INC (TRVI) - 2.05%
GABELLI DIVIDEND & INCOME TRUST (GDV) - 3.72%
#8
VERADERMICS INC (MANE) - 2.02%
NEUBERGER NXT GENERATION CNNCTVTY (NBXG) - 3.22%
#9
AMYLYX PHARMACEUTICALS INC (AMLX) - 2.00%
GENERAL AMERICAN INVESTORS CO INC (GAM) - 3.21%
#10
n/a (NUVB) - 1.95%
PIMCO DYNAMIC INCOME STRATEGY FUND (PDX) - 3.20%
#11
EDGEWISE THERAPEUTICS INC (EWTX) - 1.88%
NUVEEN S&P 500 DYNAMIC OVERWRITE FUND (SPXX) - 2.93%
#12
NEKTAR THERAPEUTICS (NKTR) - 1.82%
NEUBERGER ENERGY INFRA AND INCOME INC (NML) - 2.89%
#13
LIGAND PHARMACEUTICALS INC (LGND) - 1.81%
ROYCE MICRO-CAP TRUST (RMT) - 2.84%
#14
LIQUIDIA CORP ORDINARY SHARES (LQDA) - 1.81%
MEXICO FUND INC (MXF) - 2.45%
#15
MAZE THERAPEUTICS INC (MAZE) - 1.81%
TRI CONTINENTAL (TY) - 2.43%
#16
HARROW INC (HROW) - 1.81%
BLACKROCK TECH AND PRIVATE EQUITY TERM (BTX) - 2.24%
#17
CORCEPT THERAPEUTICS INC (CORT) - 1.74%
JAPAN SMALLER CAPITALIZATION FUND INC (JOF) - 2.08%
#18
OCULAR THERAPEUTIX INC (OCUL) - 1.73%
HIGHLAND OPPORTUNITIES AND INCOME FUND (HFRO) - 1.90%
#19
EYEPOINT INC (EYPT) - 1.70%
BNP LINE OF CREDIT SABA (n/a) - 1.65%
#20
n/a (AMRX) - 1.70%
VIRTUS TOTAL RETURN FUND INC (ZTR) - 1.65%
#21
ELANCO ANIMAL HEALTH INC (ELAN) - 1.69%
n/a (MEGI) - 1.55%
#22
PACIRA BIOSCIENCES INC (PCRX) - 1.64%
NEW GERMANY FUND INC (GF) - 1.48%
#23
n/a (INDV) - 1.63%
n/a (NIE) - 1.45%
#24
SUPERNUS PHARMACEUTICALS INC (SUPN) - 1.61%
BLACKROCK HEALTH SCIENCES TERM TRUST (BMEZ) - 1.44%
#25
VIATRIS INC (VTRS) - 1.60%
BNY MELLON STRATEGIC MUNICIPALS, INC. (LEO) - 1.40%
Total Holdings6680

XPH vs CEFS - Historical Returns

Returns include dividend reinvestment.

1M
Winner
XPH
+10.71%
CEFS
-1.82%
3M
Winner
XPH
+18.95%
CEFS
+6.08%
6M
Winner
XPH
+20.84%
CEFS
+13.33%
1Y
Winner
XPH
+64.32%
CEFS
+21.02%
5Y(CAGR)
XPH
+7.15%
Winner
CEFS
+14.07%
10Y(CAGR)
XPH
+5.25%
Winner
CEFS
+11.89%
Max(CAGR)
XPH
+9.45%
Winner
CEFS
+11.89%

XPH vs CEFS - Annual Returns (2006 - 2026)

Returns include dividend reinvestment.

YearXPHCEFS
2026+24.81%+14.77%
2025+32.67%+16.85%
2024+4.80%+23.95%
2023+3.85%+21.43%
2022-10.72%-7.25%
2021-9.89%+18.25%
2020+14.99%+3.04%
2019+24.63%+27.73%
2018-16.41%-9.86%
2017+9.20%+7.63%
2016-21.50%N/A
2015+1.71%N/A
2014+30.23%N/A
2013+58.86%N/A
2012+10.07%N/A
2011+11.81%N/A
2010+19.70%N/A
2009+25.21%N/A
2008-8.06%N/A
2007-1.40%N/A
2006+11.12%N/A

XPH vs CEFS Drawdown Comparison

The maximum drawdown for XPH was -48.04%, occurring on Mar 23, 2020. Recovery took 2621 trading sessions.

The maximum drawdown for CEFS was -39.03%, occurring on Mar 23, 2020. Recovery took 192 trading sessions.

The current XPH drawdown is -1.84%. The current CEFS drawdown is -2.06%.

RankXPHCEFS
#1-48.04%
Jul 22, 2015 - Dec 22, 2025
-39.03%
Feb 20, 2020 - Nov 20, 2020
#2-35.26%
May 9, 2007 - Oct 14, 2009
-16.84%
Nov 16, 2021 - Feb 2, 2023
#3-17.59%
Jul 7, 2011 - Jan 9, 2012
-16.63%
Jan 25, 2018 - Feb 22, 2019
#4-14.50%
Mar 5, 2014 - Jun 20, 2014
-13.36%
Feb 18, 2025 - Jun 4, 2025
#5-13.17%
Sep 18, 2012 - Feb 19, 2013
-11.03%
Aug 1, 2023 - Nov 30, 2023
#6-11.97%
Feb 25, 2026 - Apr 17, 2026
-9.98%
Feb 2, 2023 - Jun 12, 2023
#7-10.95%
Apr 5, 2010 - Sep 13, 2010
-5.93%
Jul 15, 2024 - Aug 27, 2024
#8-10.85%
Jul 3, 2014 - Sep 17, 2014
-5.85%
Mar 28, 2024 - May 10, 2024
#9-10.60%
Mar 19, 2015 - Jul 14, 2015
-5.66%
Feb 26, 2026 - Apr 9, 2026
#10-9.08%
Oct 15, 2009 - Nov 23, 2009
-4.45%
Dec 11, 2024 - Jan 17, 2025
#11-8.24%
May 6, 2026 - Jun 18, 2026
-4.29%
May 3, 2019 - Jun 20, 2019
#12-7.03%
Sep 24, 2014 - Oct 28, 2014
-3.73%
Jul 17, 2019 - Oct 16, 2019
#13-6.73%
Feb 20, 2007 - Apr 12, 2007
-3.66%
Dec 28, 2023 - Jan 26, 2024
#14-6.56%
Jan 18, 2011 - Apr 4, 2011
-3.28%
Oct 30, 2025 - Nov 28, 2025
#15-6.43%
Apr 27, 2012 - Jun 19, 2012
-3.13%
Oct 24, 2017 - Dec 20, 2017

Correlation

Correlation between XPH and CEFS is 0.70 which considered as a strong positive correlation - the stocks tend to move together.

0.70
-101

Dividend Comparison (2006 - 2026)

XPH vs CEFS dividend yield comparison.

YearXPHCEFS
20260.17%3.33%
20250.83%7.84%
20241.58%8.79%
20231.28%9.20%
20221.64%11.32%
20210.95%10.73%
20200.47%8.61%
20190.64%8.10%
20180.65%10.43%
20170.67%5.02%
20160.63%0.00%
20157.15%0.00%
20145.55%0.00%
20132.06%0.00%
20121.91%0.00%
20111.15%0.00%
20101.12%0.00%
20090.99%0.00%
20081.56%0.00%
20071.11%0.00%
20060.76%0.00%

Select Stocks to Compare